2 results
Approved WMORecruiting
Main Objective (EudraCT):To evaluate the safety and tolerability of RO7198457 when administered as a single agent (Phase [Ph] Ia) or in combination with atezolizumab (Ph Ib), with or without prophylactic treatment with corticosteroids, including…
Approved WMOCompleted
Investigate the distribution, dosimetry and image quality of [195mPt]cisplatin in cancer patients